{"id":"W3164065928","doi":"10.1002/psp4.12647","title":"Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy","year":2021,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Sanofi Genzyme; Grifols; Mitsubishi Tanabe Pharma Corporation; CSL Behring; Baxalta; Argenx; European Commission; TG Therapeutics; Sanofi","keywords":"Chronic inflammatory demyelinating polyneuropathy; Dosing; Medicine; Antibody; Placebo; Polyradiculoneuropathy; Immunoglobulin E; Immunology; Population; Internal medicine; Polyneuropathy; Pharmacodynamics; Pharmacokinetics; Immunoglobulin G; Gastroenterology; Guillain-Barre syndrome; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01097262,0.0005733119,0.0009363199,0.00191839,0.0001571862,0.0009212432,0.0004184459,0.0007085199,0.001704183],"category_scores_gemma":[0.02643356,0.0002395902,0.001551467,0.00139558,0.0005753126,0.0007494279,0.0005042679,0.0006579222,0.0002169301],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001278687,"about_ca_system_score_gemma":0.0007467997,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002559643,"about_ca_topic_score_gemma":0.0008187173,"domain_scores_codex":[0.9965141,0.002547763,0.0001520273,0.000312637,0.0003374138,0.0001360972],"domain_scores_gemma":[0.9638848,0.03126971,0.002824187,0.001230508,0.0005625818,0.0002282713],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.002414405,0.0004553991,0.2740118,0.0002182038,0.001833115,0.0001528933,0.0001058326,0.6827765,0.002133935,0.002028747,0.0006774782,0.0331917],"study_design_scores_gemma":[0.0001152361,0.001432011,0.1745,0.0000259745,0.0003877147,0.000229165,0.00007217802,0.8160595,0.001178792,0.005211153,0.0007472691,0.00004099493],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9655008,0.0006795838,0.02992722,0.0003903039,0.00001246399,0.0001767346,0.001549103,0.0002079275,0.001555859],"genre_scores_gemma":[0.9974413,0.00008719978,0.001635367,0.00003808016,0.000007301497,0.00005017061,0.0005738109,0.000008934658,0.0001578835],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01097262,"threshold_uncertainty_score":0.05802947,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03899096057079242,"score_gpt":0.3857171452933122,"score_spread":0.3467261847225198,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}